Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations
Peru SD-ART
2 other identifiers
interventional
139
1 country
2
Brief Summary
The goal of this study is to develop and implement a same-day ART (SD-ART) protocol for key affected populations with HIV in Peru. The development of the protocol will be guided by asynchronous online focus groups with HIV experts to define eligibility criteria and essential components of the protocol, as well as nominal group technique focus groups and in-depth interviews to identify barriers and facilitators to SD-ART implementation. Finally, investigators will pilot the SD-ART protocol with patients and clinicians using a prospective, longitudinal design integrated into routine HIV care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv
Started Jul 2027
Shorter than P25 for not_applicable hiv
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2025
CompletedFirst Posted
Study publicly available on registry
July 8, 2025
CompletedStudy Start
First participant enrolled
July 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
Study Completion
Last participant's last visit for all outcomes
July 1, 2028
July 8, 2025
June 1, 2025
1 year
June 26, 2025
June 26, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Reductions in patient HIV and multi-dimensional stigma
Assessed using a modified 10-item version of the Berger HIV stigma scale, which has been previously translated into Spanish and validated in Peru. Total score range from 40 to 160. Higher scores denote higher levels of HIV stigma.
baseline, month 1, month 3, month 6, month 9, and month 12
Provider stigma toward patients
Measured through feeling thermometers (on a scale from 0-100) of various identity groups (people with HIV, sexual minorities, people who use drugs).
baseline, month 1, month 3, month 6, month 9, and month 12
Everyday Discrimination Scale
This is a 5-item scale that is rated on a 6-point scale (range from 0 to 30), with higher scores denoting higher levels of multi-dimensional stigma and experiences with discrimination
baseline, month 1, month 3, month 6, month 9, and month 12
Study Arms (2)
People With HIV (PWH)
EXPERIMENTALSD-ART protocol for PWH prescribed by their HIV clinicians
Clinicians prescribing ART
NO INTERVENTIONInterventions
SD-ART protocol for PWH with both patients and their HIV clinicians
Eligibility Criteria
You may qualify if:
- Aim 1:
- HIV experts will be selected from National Societies of HIV experts according to the following criteria: 1) 18 years old or older; 2) Be an HIV expert, including those from NGOs providing HIV care, and international specialists; 3) Provide informed consent.
- Aim 2:
- NGT Focus Groups (FG)
- Staff members
- years old or older.
- Be a clinical staff member at Hospital Dos de Mayo or Patrucco Primary Health Center.
- Provide informed consent.
- PWH receiving HIV care
- years old or older.
- Identify as member of a KAP.
- Receive HIV care at Hospital Dos de Mayo or Patrucco Primary Health.
- Provide informed consent.
- PWH who dropped out of HIV care
- years old or older.
- +18 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Institutes of Health (NIH)collaborator
Study Sites (2)
Centro de Salud Raul Patrucco Puig
Lima, Peru
Hospital Dos de Mayo
Lima, Peru
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frederick Altice, M.D., M.A
Yale University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2025
First Posted
July 8, 2025
Study Start (Estimated)
July 1, 2027
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
July 8, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share